Genesis Growth Tech Acquisition filed a proxy and prospectus on its $21 million deal with MindMaze, a digital therapeutics firm. The sponsor is obligated to pay MindMaze the $21 million purchase price by May 31. The parties have also agreed to share certain revenues. The SPAC’s sponsor currently owns 6,325,000 Class B shares, representing approximately 98.7% of the outstanding ordinary shares, and 8,875,000 warrants to purchase a like number of Class A shares at $11.50 each.
Genesis Growth Tech Files Proxy on MindMaze Deal
